Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Minke A E Rab; Jennifer Bos; Brigitte van Oirschot; Stephanie van Straaten; Penelope A Kosinski; Victor Chubukov; Hyeryun Kim; Heidi Mangus; Roger E G Schutgens; Gerard Pasterkamp; Lenny Dang; Charles Kung; Eduard J van Beers; Richard van Wijk

doi:10.1182/blood.2020008635

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Minke A E Rab, Jennifer Bos, Brigitte van Oirschot, Stephanie van Straaten, Penelope A Kosinski, Victor Chubukov, Hyeryun Kim, Heidi Mangus, Roger E G Schutgens, Gerard Pasterkamp, Lenny Dang, Charles Kung, Eduard J van Beers, Richard van Wijk

Research output: Contribution to journal › Letter › Academic › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	2997-3001
Number of pages	5
Journal	Blood
Volume	137
Issue number	21
Early online date	10 Mar 2021
DOIs	https://doi.org/10.1182/blood.2020008635
Publication status	Published - 27 May 2021

Access to Document

10.1182/blood.2020008635

Cite this

Rab, M. A. E., Bos, J., van Oirschot, B., Straaten, S. V., Kosinski, P. A., Chubukov, V., Kim, H., Mangus, H., Schutgens, R. E. G., Pasterkamp, G., Dang, L., Kung, C., van Beers, E. J., & van Wijk, R. (2021). Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. Blood, 137(21), 2997-3001. https://doi.org/10.1182/blood.2020008635

@article{10a011f75d544c9ea198074fef1cddc9,

title = "Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy",

author = "Rab, {Minke A E} and Jennifer Bos and {van Oirschot}, Brigitte and Straaten, {Stephanie van} and Kosinski, {Penelope A} and Victor Chubukov and Hyeryun Kim and Heidi Mangus and Schutgens, {Roger E G} and Gerard Pasterkamp and Lenny Dang and Charles Kung and {van Beers}, {Eduard J} and {van Wijk}, Richard",

note = "Funding Information: This research has been funded, in part, by Agios Pharmaceuticals Inc and the Eurostars Program (SCOOP, ESTAR18105).",

year = "2021",

month = may,

day = "27",

doi = "10.1182/blood.2020008635",

language = "English",

volume = "137",

pages = "2997--3001",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

Rab, MAE, Bos, J, van Oirschot, B, Straaten, SV, Kosinski, PA, Chubukov, V, Kim, H, Mangus, H, Schutgens, REG , Pasterkamp, G, Dang, L, Kung, C, van Beers, EJ & van Wijk, R 2021, 'Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy', Blood, vol. 137, no. 21, pp. 2997-3001. https://doi.org/10.1182/blood.2020008635

TY - JOUR

T1 - Decreased activity and stability of pyruvate kinase in sickle cell disease

T2 - a novel target for mitapivat therapy

AU - Rab, Minke A E

AU - Bos, Jennifer

AU - van Oirschot, Brigitte

AU - Straaten, Stephanie van

AU - Kosinski, Penelope A

AU - Chubukov, Victor

AU - Kim, Hyeryun

AU - Mangus, Heidi

AU - Schutgens, Roger E G

AU - Pasterkamp, Gerard

AU - Dang, Lenny

AU - Kung, Charles

AU - van Beers, Eduard J

AU - van Wijk, Richard

N1 - Funding Information: This research has been funded, in part, by Agios Pharmaceuticals Inc and the Eurostars Program (SCOOP, ESTAR18105).

PY - 2021/5/27

Y1 - 2021/5/27

UR - http://www.scopus.com/inward/record.url?scp=85106915227&partnerID=8YFLogxK

U2 - 10.1182/blood.2020008635

DO - 10.1182/blood.2020008635

M3 - Letter

C2 - 33690814

SN - 0006-4971

VL - 137

SP - 2997

EP - 3001

JO - Blood

JF - Blood

IS - 21

ER -

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Access to Document

Other files and links

Cite this